| A comparison of seven random‐effects models for meta‐analyses that estimate the summary odds ratio D Jackson, M Law, T Stijnen, W Viechtbauer, IR White Statistics in medicine 37 (7), 1059-1085, 2018 | 174 | 2018 |
| Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease GC Donaldson, M Law, B Kowlessar, R Singh, SE Brill, JP Allinson, ... American journal of respiratory and critical care medicine 192 (8), 943-950, 2015 | 154 | 2015 |
| The Hartung‐Knapp modification for random‐effects meta‐analysis: A useful refinement but are there any residual concerns? D Jackson, M Law, G Rücker, G Schwarzer Statistics in medicine 36 (25), 3923-3934, 2017 | 134 | 2017 |
| Some recommendations for multi-arm multi-stage trials J Wason, D Magirr, M Law, T Jaki Statistical methods in medical research 25 (2), 716-727, 2016 | 108 | 2016 |
| Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial SE Brill, M Law, E El-Emir, JP Allinson, P James, V Maddox, ... Thorax 70 (10), 930-938, 2015 | 85 | 2015 |
| Two new methods to fit models for network meta-analysis with random inconsistency effects M Law, D Jackson, R Turner, K Rhodes, W Viechtbauer BMC Medical Research Methodology 16 (87), 2016 | 53 | 2016 |
| Editor's choice–the implications of non-compliance to endovascular aneurysm repair surveillance: a systematic review and meta-analysis MJ Grima, M Boufi, M Law, D Jackson, K Stenson, B Patterson, I Loftus, ... European Journal of Vascular and Endovascular Surgery 55 (4), 492-502, 2018 | 50 | 2018 |
| Extending DerSimonian and Laird's methodology to perform network meta‐analyses with random inconsistency effects D Jackson, M Law, JK Barrett, R Turner, JPT Higgins, G Salanti, IR White Statistics in medicine 35 (6), 819-839, 2016 | 39 | 2016 |
| A matrix‐based method of moments for fitting multivariate network meta‐analysis models with multiple outcomes and random inconsistency effects D Jackson, S Bujkiewicz, M Law, RD Riley, IR White Biometrics 74 (2), 548-556, 2018 | 36 | 2018 |
| Paule‐Mandel estimators for network meta‐analysis with random inconsistency effects D Jackson, AA Veroniki, M Law, AC Tricco, R Baker Research synthesis methods 8 (4), 416-434, 2017 | 22 | 2017 |
| Residual plots for linear regression models with censored outcome data: A refined method for visualizing residual uncertainty M Law, D Jackson Communications in Statistics-Simulation and Computation 46 (4), 3159-3171, 2017 | 21 | 2017 |
| Two new approaches for the visualisation of models for network meta-analysis M Law, N Alam, AA Veroniki, Y Yu, D Jackson BMC Medical Research Methodology 19, 1-18, 2019 | 9 | 2019 |
| Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin. A double-blind, randomized, placebo-controlled … AI Ritchie, SE Brill, BH Vlies, LJ Finney, JP Allinson, L Alves-Moreira, ... American journal of respiratory and critical care medicine 202 (4), 549-557, 2020 | 8 | 2020 |
| A stochastically curtailed single‐arm phase II trial design for binary outcomes M Law, MJ Grayling, AP Mander Journal of biopharmaceutical statistics 32 (5), 671-691, 2022 | 7* | 2022 |
| Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacy MR Wilkins, MA Mckie, M Law, AA Roussakis, L Harbaum, C Church, ... Pulmonary Circulation 11 (4), 20458940211052823, 2021 | 7 | 2021 |
| A double-blind, randomized, placebo-controlled trial of long-term doxycycline therapy on exacerbation rate in patients with stable chronic obstructive pulmonary disease JP Allinson, BH Vlies, SE Brill, M Law, G Burnside, LJ Finney, ... American journal of respiratory and critical care medicine 208 (5), 549-558, 2023 | 5 | 2023 |
| A stochastically curtailed two‐arm randomised phase II trial design for binary outcomes M Law, MJ Grayling, AP Mander Pharmaceutical statistics 20 (2), 212-228, 2021 | 4 | 2021 |
| Misspecification of at-risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation M Law, MJ Sweeting, G Donaldson, JA Wedzicha Pharmaceutical Statistics, 2016 | 4 | 2016 |
| Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research … M Law, DL Couturier, B Choodari-Oskooei, P Crout, C Gamble, P Jacko, ... Trials 24 (1), 640, 2023 | 3 | 2023 |
| Exact Likelihood Methods for Group-Based Summaries T Stijnen, CH Schmid, M Law, D Jackson, IR White Handbook of Meta-Analysis, 2020 | 3 | 2020 |
Dan JacksonAstraZeneca在 astrazeneca.com 的电子邮件经过验证
